ketamine has been researched along with Hemimegalencephaly in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Hemimegalencephaly: Rare MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP I characterized by the enlargement of one side of the brain. It is associated with seizures, partial paralysis, and mental retardation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brisca, G | 1 |
| Pirlo, D | 1 |
| Prato, G | 1 |
| Tortora, D | 1 |
| Siri, L | 1 |
| Nobili, L | 1 |
| Tardini, G | 1 |
| Consales, A | 1 |
| Moscatelli, A | 1 |
| Buratti, S | 1 |
1 other study available for ketamine and Hemimegalencephaly
| Article | Year |
|---|---|
Efficacy of Ketamine Use in Refractory Status Epilepticus Associated With Hemimegalencephaly.
Topics: Anticonvulsants; Hemimegalencephaly; Humans; Ketamine; Status Epilepticus | 2022 |